The FH phenotype is caused by loss of function variants in the LDLR gene in 60–80% patients, followed by those in APOB (5–10%) or by gain-of-function variants in PCSK9 (<1%) [6]. The gene discussed is PCSK9; the disease is familial hyperaldosteronism.